Jim Flatt has a 35-year track record of transforming scientific breakthroughs and advances in technology into popular health products. Prior to founding Brightseed, he was CTO for Synthetic Genomics, a leader in synthetic biology, that developed new products in partnership with leading Fortune 100 companies, including Novartis, ExxonMobil, Monsanto and ADM. He led R&D at Martek Biosciences, a leader in developing fatty acid nutritional products for infant brain and eye development, and cardiovascular health, and oversaw the design and construction of the first large-scale microalgae production facility. He has led breakthroughs in producing biofuels from yeasts and bacteria with energy research company Mascoma and developed plant-based food products and novel plant-based protein ingredients with food manufacturer Hampton Creek. Jim is a chemical and biochemical engineer with a PhD from the University of Wisconsin and degrees from MIT and UC Berkeley.
Humanity is at its best when we shoot for the moon. The most famous moonshot was the one that got us to the moon in 1969. But the past few decades have been full of other major advances, ...
The COVID-19 pandemic didn’t just transform how we work and communicate. It also accelerated the need for more proactive health measures for chronic health problems tied to diet. Such pro...
